11/10
04:55 pm
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
11/10
04:55 pm
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
11/7
03:08 pm
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
11/7
10:46 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
11/7
10:46 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
10/28
09:10 am
ptgx
Rating for PTGX
Medium
Report
Rating for PTGX
10/28
09:10 am
ptgx
Rating for PTGX
Medium
Report
Rating for PTGX
10/28
08:09 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $82.00 price target on the stock.
Medium
Report
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $82.00 price target on the stock.
10/28
05:18 am
ptgx
Rating for PTGX
Medium
Report
Rating for PTGX
10/17
11:28 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
10/17
11:28 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
10/17
07:20 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/13
09:07 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
High
Report
Protagonist Therapeutics (NASDAQ:PTGX) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
10/8
08:09 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Low
Report
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
9/18
06:44 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Medium
Report
Protagonist Therapeutics (NASDAQ:PTGX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
9/17
11:46 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Low
Report
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
9/17
08:05 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $72.00 price target on the stock.
Low
Report
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $72.00 price target on the stock.
9/17
06:55 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
9/17
06:55 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
9/16
04:56 pm
ptgx
Protagonist Therapeutics initiated with an Overweight at Barclays
Low
Report
Protagonist Therapeutics initiated with an Overweight at Barclays
9/16
04:56 pm
ptgx
Protagonist Therapeutics initiated with an Overweight at Barclays
Low
Report
Protagonist Therapeutics initiated with an Overweight at Barclays
9/16
04:17 pm
ptgx
Protagonist Therapeutics initiated with an Overweight at Barclays
Low
Report
Protagonist Therapeutics initiated with an Overweight at Barclays
9/16
04:17 pm
ptgx
Protagonist Therapeutics initiated with an Overweight at Barclays
Low
Report
Protagonist Therapeutics initiated with an Overweight at Barclays
9/12
08:03 am
ptgx
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $73.00 price target on the stock.
Low
Report
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $73.00 price target on the stock.
9/12
06:55 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX